Skip to main content
Equibles
TKNO logo

TKNO · Alpha Teknova, Inc.

Track TKNO — free

Use TKNO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TKNO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.29 -0.09 (-1.22%) At close · Aug 14
Market Cap
$391.39M
Shares
53.69M

Alpha Teknova, Inc. Earnings Call Transcripts

Every quarterly earnings call for Alpha Teknova, Inc. (TKNO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲13.8% $10.69M −$22.47M '22 Q3 22-11-09 ▼21.9% $7.89M −$13.29M '22 Q4 23-03-15 ▼18.2% $9.12M −$8.82M '23 Q1 23-05-10 ▼1.4% $11.53M −$7.15M '23 Q2 23-08-10 ▼23.6% $8.17M −$10.15M '23 Q3 23-11-09 ▼0.3% $7.87M −$10.66M '23 Q4 24-03-11 ▲1.9% $9.29M −$8.10M '24 Q1 24-05-13 ▼16.6% $9.61M −$5.36M '24 Q2 24-07-09 ▲17.2% $9.58M −$7.57M '24 Q3 24-11-07 ▲17.8% $9.27M −$5.72M '24 Q4 25-03-04 ▲5.4% $9.79M −$4.64M '25 Q1 25-05-08 ▲7% $10.29M −$3.57M '25 Q2 25-08-07 ▲9.2% $10.45M −$4.29M '25 Q3 25-11-06 ▲7.8% $9.98M −$4.76M '25 Q4 26-02-26 ▲13.1% $11.08M −$4.55M '26 Q1 26-05-06 LATEST ▲18.5% $12.19M −$3.17M '26 Q2 26-08-05
Conference
Investor event
2026-09-29
5th Annual ROTH Healthcare Opportunities Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-19
Sidoti Micro-Cap Virtual Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
Confident tone Biotech funding environment Clinical pipeline and commercialization tailwinds BuildPet / BuildTech AI configurator launch
Revenue
$12.19M
▲ 18.5% YoY
Diluted EPS
$-0.06
Gross margin
40.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Alpha Teknova, Inc. Q1 FY2026 Earnings Call
Positive tone Revenue growth and end market stabilization Clinical Solutions momentum Path to 2027 ~20% revenue growth
Revenue
$11.08M
▲ 13.1% YoY
Diluted EPS
$-0.08
Gross margin
34.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Alpha Teknova, Inc. Q4 FY2025 Earnings Call
Confident tone GMP clinical / therapy growth Cash usage and path to EBITDA positive Margin and operating leverage outlook
Revenue
$9.98M*
▲ 7.8% YoY
Gross margin
32.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Alpha Teknova, Inc. Q3 FY2025 Earnings Call
Positive tone Clinical Solutions / GMP pipeline Lab Essentials and catalog product growth Biopharma end-market weakness
Revenue
$10.45M
▲ 9.2% YoY
Diluted EPS
$-0.08
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Alpha Teknova, Inc. Q2 FY2025 Earnings Call
Confident tone Catalog products growth Custom clinical reagents Guidance and outlook
Revenue
$10.29M
▲ 7% YoY
Diluted EPS
$-0.07
Gross margin
38.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Alpha Teknova, Inc. Q1 FY2025 Earnings Call
Positive tone Custom products to biopharma (clinical) Collaboration / M&A (Pluristics) Custom products to life science tools and diagnostics
Revenue
$9.79M
▲ 5.4% YoY
Diluted EPS
$-0.09
Gross margin
30.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Alpha Teknova, Inc. Q4 FY2024 Earnings Call
Revenue
$9.27M*
▲ 17.8% YoY
Gross margin
23.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Alpha Teknova, Inc. Q3 FY2024 Earnings Call
Positive tone Revenue Growth and Clinical Solutions Momentum Biopharma Market Environment Gross Margin and Inventory Charge
Revenue
$9.58M
▲ 17.2% YoY
Diluted EPS
$-0.15
Gross margin
0.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-09
Alpha Teknova, Inc. Q2 FY2024 Earnings Call
Positive tone Revenue performance and guidance New product launches (RUO+ and Express-Tek) Market environment and biotech funding
Revenue
$9.61M
▼ 16.6% YoY
Diluted EPS
$-0.13
Gross margin
29.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Alpha Teknova, Inc. Q1 FY2024 Earnings Call
Positive tone Revenue and 2024 Guidance Gross Margin Leverage Capital Expenditures
Revenue
$9.29M
▲ 1.9% YoY
Diluted EPS
$-0.20
Gross margin
23.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-11
Alpha Teknova, Inc. Q4 FY2023 Earnings Call
Cautious tone Clinical Solutions / cell and gene therapy growth Lab Essentials SKU rationalization and customer count Gross margin compression
Revenue
$7.87M*
▼ 0.3% YoY
Gross margin
17.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Alpha Teknova, Inc. Q3 FY2023 Earnings Call
Revenue
$8.17M
▼ 23.6% YoY
Diluted EPS
$-0.34
Gross margin
18.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Alpha Teknova, Inc. Q2 FY2023 Earnings Call
Revenue
$11.53M
▼ 1.4% YoY
Diluted EPS
$-0.25
Gross margin
43.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Alpha Teknova, Inc. Q1 FY2023 Earnings Call
Revenue
$9.12M
▼ 18.2% YoY
Diluted EPS
$-0.31
Gross margin
26.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
Alpha Teknova, Inc. Q4 FY2022 Earnings Call
Revenue
$7.89M*
▼ 21.9% YoY
Gross margin
26.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Alpha Teknova, Inc. Q3 FY2022 Earnings Call
Revenue
$10.69M
▲ 13.8% YoY
Diluted EPS
$-0.80
Gross margin
44.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Alpha Teknova, Inc. Q2 FY2022 Earnings Call
Revenue
$11.69M
▲ 40.6% YoY
Diluted EPS
$-0.22
Gross margin
44.9%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Alpha Teknova, Inc. Q1 FY2022 Earnings Call
Revenue
$11.15M
▲ 22.8% YoY
Diluted EPS
$-0.20
Gross margin
48.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
Alpha Teknova, Inc. Q4 FY2021 Earnings Call
Revenue
$10.11M*
Gross margin
49.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Alpha Teknova, Inc. Q3 FY2021 Earnings Call
Revenue
$9.39M
▲ 4.5% YoY
Diluted EPS
$-0.12
▼ 271.4% YoY
Gross margin
45.4%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Alpha Teknova, Inc. Q2 FY2021 Earnings Call
Revenue
$8.31M
▲ 37.5% YoY
Diluted EPS
$-0.52
▼ 2700% YoY
Gross margin
40.3%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 1850902 CUSIP 02080L102 13F (30d) 77 filings 76 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)